Procept biorobotics stock.
PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based …
Matt Bacso: Good afternoon, and thank you for joining PROCEPT BioRobotics third quarter 2023 earnings conference call. Presenting on today’s call are Reza Zadno, Chief Executive Officer; and ...Nov 29, 2023 · B. Riley Lowers PROCEPT BioRobotics' PT to $55 From $60 on Lower Multiple, Keeps Buy Rating. Nov. 02. MT. Transcript : PROCEPT BioRobotics Corporation, Q3 2023 Earnings Call, Nov 01, 2023. Nov. 01. CI. Earnings Flash (PRCT) PROCEPT BIOROBOTICS Posts Q3 Revenue $35.1M, vs. Street Est of $33.4M. Nov. 01. Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level …PROCEPT BioRobotics Trading Up 0.8 %. NASDAQ PRCT opened at $37.36 on Monday. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -16.03 and a beta of 0.98.Mar 27, 2023 · Procept Biorobotics Corp’s ( PRCT) price is currently down 24.19% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.28. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.30. Year to date, Procept Biorobotics Corp ...
Aug 2, 2023 · In addition, PROCEPT BioRobotics has granted the underwriters a 30-day option to purchase up to an additional 663,325 shares of its common stock at the public offering price, less underwriting ... PROCEPT BioRobotics Corporation (PRCT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 37.36 +0.29 (+0.78%) At close: 04:00PM EST. 37.36 0.00 (0.00%) After hours: 04:14PM...
The PROCEPT BioRobotics 52-week low stock price is $24.83. What is the market capitalisation of PROCEPT BioRobotics PRCT? As of 01/12/2023 PROCEPT BioRobotics has a market cap of $1.9B.
Inside Procept Biorobotics Corp's 10-K Annual Report: ... compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses, though it may fluctuate from quarter to quarter. ...Procept BioRobotics stock rises as B Riley starts coverage with buy rating, $53 PT SA News Thu, Jun. 23, 2022. Procept BioRobotics gets additional positive coverage policies for prostate gland ...On a more positive note, William Blair initiated coverage on PROCEPT BioRobotics with an “outperform” rating on the stock back in May. Based on data compiled by Bloomberg, PROCEPT BioRobotics currently holds a consensus rating of “Moderate Buy” among equity research analysts, with a consensus target price of $45.60 indicating optimism ...PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.
Procept BioRobotics stock rises as B Riley starts coverage with buy rating, $53 PT SA News Thu, Jun. 23, 2022. Procept BioRobotics gets additional positive coverage policies for prostate gland ...
Get the latest Procept Biorobotics Corp (PRCT) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financials, income statement, balance sheet, cash flow, and more on Google Finance.
PROCEPT BioRobotics Corporation (PRCT) Stock Price, Quote, News & Analysis PRCT PROCEPT BioRobotics Corporation Stock Price & Overview $33.06 …REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader... Menu icon A vertical stack of three evenly ...PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.BofA Securities. Buy. $48. Show Previous Ratings. Nov-15-23 01:03AM. Insider Sell Alert: Director Morgan Wood Sells 25,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com) Nov-13-23 04:03PM. PROCEPT BioRobotics to Present at the 35 Annual Piper Sandler Healthcare Conference in New York City. About PROCEPT BioRobotics Stock. PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided …Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 20.7% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $37.29 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.90. Year ...PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...
PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial ...REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the closing of its upsized initial public offering of 7,539,400 shares of its ...10 stocks we like better than PROCEPT BioRobotics Corporation When o ur award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade ...PROCEPT BioRobotics Stock Performance. NASDAQ:PRCT opened at $33.77 on Wednesday. The stock has a 50-day simple moving average of $31.03 and a two-hundred day simple moving average of $32.99 ...View 13F filing holders of Procept BioRobotics Corp. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers.About PROCEPT BioRobotics Corporation PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic ...PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...
Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 20.09% so far this month. During the month of October, Procept Biorobotics Corp’s stock price has reached a high of $33.00 and a low of $26.13. Over the last year, Procept Biorobotics Corp has hit prices as high as $47.75 and as low as $25.29 ...PROCEPT BioRobotics will host a conference call to discuss the first quarter 2023 financial results on Thursday, April 27, 2023, at 8:00 a.m. Eastern Time. Investors interested in listening to the ...
PROCEPT BioRobotics Corporation (PRCT) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 37.36 +0.29 (+0.78%) At close: 04:00PM EST. 37.36 0.00 (0.00%) After hours: 04:14PM... When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).Feb 28, 2023 · PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago. PROCEPT BioRobotics has raised $348.84M over 8 rounds. PROCEPT BioRobotics's latest funding round was a IPO for $163.9M on September 15, 2021. PROCEPT BioRobotics's latest post-money valuation is from September 2021. Sign up for a free demo to see PROCEPT BioRobotics's valuations in September 2021 and more. …PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by ...PROCEPT BioRobotics Corporation has completed an IPO in the amount of $163.9 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,556,000Aug 1, 2023 · REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care ...
During the first quarter of this year, abrdn plc raised its position in PROCEPT BioRobotics by an astonishing 34.6%, acquiring an additional 28,270 shares of the company’s stock. As a result, this institutional investor now owns a total of 109,944 shares worth approximately $3,122,000 as of the most recent quarter-end.
PROCEPT BioRobotics is reporting earnings from Q3 on November 1. Wall Street analysts expect PROCEPT BioRobotics will release losses per share of $0.529. Track PROCEPT BioRobotics stock price in ...
Contact Email [email protected]. Phone Number 650-232-7200. PROCEPT is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in ...PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued a report on the stock in […]According to the issued ratings of 6 analysts in the last year, the consensus rating for PROCEPT BioRobotics stock is Buy based on the current 6 buy ratings for PRCT. The average twelve-month price prediction for PROCEPT BioRobotics is $43.00 with a high price target of $49.00 and a low price target of $37.00.Complete PROCEPT BioRobotics Corp. stock information by Barron's. View real-time PRCT stock price and news, along with industry-best analysis.Procept wrote in a revised S-1 filing with the U.S. Securities and Exchange Commission that it intends to offer 5.5M shares of its stock at an expected $22-$24/range. The company is also granting ...REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter endedOct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ... PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2022. Recent …
PROCEPT BioRobotics Corporation reported 135% YoY Q3 revenue growth to $20.3mm. Growth was underscored by robotic system sales and utilization from current placements. ... The stock has climbed 74 ...PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with an initial ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that certainly holds water.Instagram:https://instagram. how to identify real gold at homeanonymous llc in delawarebark stockbcpc According to 5 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $48.4 with a high of $55.00 and a low of $43.00. alt stockc3.ai earnings What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...PROCEPT BioRobotics® Corporation announced the pricing of an upsized underwritten public offering of 4,422,169 shares of its common stock at a public offering ... ewa stock PRCT | Complete PROCEPT BioRobotics Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial ...The PROCEPT BioRobotics Corporation stock forecast for tomorrow is $ 32.89, which would represent a -0.51% loss compared to the current price. In the next week, the price of PRCT is expected to increase by 7.80% and hit $ 35.64.. As far as the long-term PROCEPT BioRobotics Corporation stock forecast is concerned, here’s what our predictions are …